We are live on ! Find out more
ACM

Altium Capital Management Portfolio holdings

AUM $42M
This Fund
S&P 500
This Quarter Est. Return
-7.52%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$250M
AUM Growth
-$48.9M
Cap. Flow
-$2.79M
Cap. Flow %
-1.12%
Top 10 Hldgs %
27.41%
Holding
148
New
29
Increased
17
Reduced
14
Closed
22

Top Buys

Rank Stock Value
1
PEPL
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
+$7.25M
2
GH icon
Guardant Health
GH
+$5.2M
3
STAA icon
STAAR Surgical
STAA
+$4.83M
4
INGN icon
Inogen
INGN
+$4.14M
5
CCXI
ChemoCentryx, Inc.
CCXI
+$3.53M

Top Sells

Rank Stock Value
1
ESPR
Esperion Therapeutics
ESPR
+$7.56M
2
PEPLU
PepperLime Health Acquisition Corporation Unit
PEPLU
+$7.23M
3
GMED icon
Globus Medical
GMED
+$5.83M
4
TNDM icon
Tandem Diabetes Care
TNDM
+$5.82M
5
BCYC
Bicycle Therapeutics
BCYC
+$5.27M

Sector Composition

Rank Sector Weight
1 Healthcare 73.54%
2 Financials 11.69%
3 Industrials 1.28%
4 Technology 0.99%
5 Consumer Discretionary 0.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TGVCU
51
DELISTED
TG Venture Acquisition Corp. Units
TGVCU
$2M 0.8%
200,000
– –
LAAA
52
DELISTED
Lakeshore Acquisition I Corp. Ordinary Shares
LAAA
$2M 0.8%
200,000
– –
MOBX icon
53
Mobix Labs
MOBX
$26.7M
$2M 0.8%
20,000
– –
JYAC
54
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$1.98M 0.79%
200,000
– –
AXSM icon
55
PUT
Axsome Therapeutics
AXSM
$11B
$1.92M 0.77%
+50,000
New +$1.58M
HLMN icon
56
Hillman Solutions
HLMN
$1.79B
$1.91M 0.76%
221,000
+25,000
+13% +$275K
ILMN icon
57
Illumina
ILMN
$30.2B
$1.84M 0.74%
10,280
-1,028
-9% -$263K
EYPT icon
58
EyePoint Inc
EYPT
$1.03B
$1.77M 0.71%
224,541
– –
KRTX
59
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1.65M 0.66%
13,000
-8,000
-38% -$919K
AGIO icon
60
Agios Pharmaceuticals
AGIO
$1.89B
$1.62M 0.65%
73,000
+6,804
+10% +$154K
POL.WS
61
DELISTED
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
$1.59M 0.64%
6,103,824
– –
OM icon
62
Outset Medical
OM
$96.8M
$1.54M 0.62%
6,925
+3,458
+100% +$1.49M
DHACU
63
DELISTED
Digital Health Acquisition Corp. Unit
DHACU
$1.51M 0.61%
150,000
– –
ADRT
64
DELISTED
Ault Disruptive Technologies Corporation
ADRT
$1.5M 0.6%
150,000
– –
RZLT icon
65
Rezolute
RZLT
$451M
$1.33M 0.53%
+411,000
New +$1.37M
MORF
66
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$1.3M 0.52%
60,000
– –
BURU
67
DELISTED
NUBURU INC
BURU
$1.28M 0.51%
643
– –
IMGN
68
DELISTED
Immunogen Inc
IMGN
$1.26M 0.5%
280,000
-640,000
-70% -$2.78M
ALT icon
69
Altimmune
ALT
$589M
$1.15M 0.46%
98,659
-223,341
-69% -$1.38M
RXDX
70
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$1.1M 0.44%
+39,000
New +$1.13M
TSVT
71
DELISTED
2seventy bio
TSVT
$1.1M 0.44%
83,000
-32,000
-28% -$436K
RACYU
72
DELISTED
Relativity Acquisition Corp. Unit
RACYU
$1.02M 0.41%
100,000
– –
MURFU
73
DELISTED
Murphy Canyon Acquisition Corp. Unit
MURFU
$1.01M 0.4%
100,000
– –
AXH
74
DELISTED
Industrial Human Capital, Inc.
AXH
$1M 0.4%
100,000
– –
WAVSU
75
DELISTED
Western Acquisition Ventures Corp. Unit
WAVSU
$1M 0.4%
100,000
– –
1 2
3
4 5

Similar funds

TA
TLS Advisors Miami, Florida $42.1M AUM 25.99% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
LSA
Liberty Street Advisors New York $41.4M AUM 34.47% 1-Year Est. Return
VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return

Altium Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Altium Capital Management held 148 positions worth $250M, down 16% from $299M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Altium Capital Management's Q2 2022 filing shows 29 new, 17 increased, 14 reduced and 22 closed positions. Its largest new stake was PepperLime Health Acquisition Corporation Class A Ordinary Share: 735,000 shares worth $7.25M. The largest sale was Esperion Therapeutics, an estimated $7.56M.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, down from 78% a quarter earlier, followed by Financials and Industrials.

  • Altium Capital Management's largest Q2 2022 buy was PepperLime Health Acquisition Corporation Class A Ordinary Share: 735,000 shares worth $7.25M.
  • Altium Capital Management added most to Lantheus in Q2 2022, an estimated $3.03M increase.
  • Altium Capital Management's biggest Q2 2022 reduction was Esperion Therapeutics, cutting an estimated $7.56M.
  • Altium Capital Management fully exited PepperLime Health Acquisition Corporation Unit in Q2 2022, selling an estimated $7.23M.
  • Altium Capital Management's ten largest holdings make up 27% of its $250M portfolio in Q2 2022.
  • Altium Capital Management opened 29 new positions and closed 22 in Q2 2022.
  • Altium Capital Management's portfolio value fell 16% quarter-over-quarter to $250M.

Based on Altium Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.